AETHLON MEDICAL INC
AEMD · XNASCIK 882291fmd_1HGEYZZARCYV3W6TK9C6530WK2Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Apr 01, 2010 to Sep 30, 2026, 66 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | – | – |
| Research and development | 1 | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 2 | 2 |
| Compensation and benefits | 3 | 3 | 3 | 2 | 3 | 5 | 4 | 5 | 4 | 3 |
| Total operating expenses | 6 | 5 | 6 | 7 | 9 | 11 | 12 | 13 | 9 | 7 |
| Operating income | (6) | (5) | (6) | (6) | (8) | (10) | (12) | (13) | (9) | (7) |
| Interest expense | 0 | 0 | 0 | 0 | 0 | – | – | – | 0 | 0 |
| Interest and investment income | – | – | – | – | – | – | – | – | 0 | 0 |
| Other non-operating income (expense) | – | – | (0) | (0) | (0) | – | – | – | (4) | 0 |
| Income before taxes | – | – | – | – | – | – | – | – | (13) | (7) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | – | – | – | – | – | – | – | (13) | (7) |
| Net income | (7) | (6) | (6) | (6) | (8) | (10) | (12) | (12) | (13) | (7) |